Condition: Psoriasis · Sponsor: Bristol-Myers Squibb
The purpose of this study is to assess the real-world effectiveness of deucravacitinib treatment in adults diagnosed with moderate-to-severe plaque psoriasis
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Chu Amiens Picardie - Site Sud | Amiens, France | Recruiting |
| Cabinet Médical Elisabeth Lion | Angers, France | Recruiting |
| Ch Victor Dupouy | Argenteuil, France | Recruiting |
| Local Institution - 089 | Argenteuil, France | Completed |
| CH ARRAS | Arras, France | Recruiting |
| Cabinet Dermatologie | Bordeaux, France | Recruiting |
| Cabinet Dermatologie | Bordeaux, France | Recruiting |
| Centre Hospitalier William Morey - Hématologie | Chalon-sur-Saône, France | Recruiting |
| Local Institution - 053 | Clermont-Ferrand, France | Completed |
| CHU Dijon | Dijon, France | Recruiting |
| Local Institution - 077 | Dijon, France | Not Yet Recruiting |
| CHU Grenoble Alps, Service de Dermatologie | La Tronche, France | Recruiting |
+ 36 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.